Every person is unique. We can clearly see this within the more than one million genomic profiles from 70
Third party sequencing services can enable increased access to NGS testing, but if institutions do not receive access to
SOPHiA GENETICS has reached a major milestone on a global scale by analyzing one million genomic profiles.
The field of precision medicine continues to evolve but remains steadfast in its goal to provide the right treatment
Larger panels may cast wider nets, but optimization with patented algorithms through our universal platform gives more actionable insights
Increased access to genomic testing can help fulfill the promise of making precision medicine accessible to all, but the
By leveraging expertly curated evidence, powered by JAX-CKB, and SOPHiA GENETICS’ patented algorithms through the SOPHiA DDM platform, users
The President acknowledged that the US still has much further to come in advancing data-driven initiatives and that many
2021 has been a big year for SOPHiA GENETICS. Here's a recap of some of the major highlights...
Radiomics maximizes upon information that’s already being collected. The difference is how that info is used.
About half of all breast cancer patients develop the disease outside of the period of ages 50-69 and could
Think of it like trying to find a treasure buried on a beach. It would be a lot easier
